OGN:NYSE
Organon & Co
13,81 $
arrow_upward
+0,44%(+0,060) 1D
13,81 $
0,00% (0,00)
bedtimeAfter hours
Closed: 9 հոկ, 16:00:07 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
13,76 $
High
13,83 $
Low
13,75 $
Mkt. cap
3,63 մլրդ
Avg. vol.
2,60 մլն
Volume
3,26 մլն
Dividend
0,58%
Quarterly dividend
0,02 $
Ex-dividend date
14 օգս, 2026 թ.
P/E ratio
17,69
52-wk high
13,83 $
52-wk low
5,69 $
EPS
0,78 $
Beta
1,55
Shares outstanding
262,61 մլն
No. of employees
10 հզր
Open
13,76 $
High
13,83 $
Low
13,75 $
Mkt. cap
3,63 մլրդ
Avg. vol.
2,60 մլն
Volume
3,26 մլն
Dividend
0,58%
Quarterly dividend
0,02 $
Ex-dividend date
14 օգս, 2026 թ.
P/E ratio
17,69
52-wk high
13,83 $
52-wk low
5,69 $
EPS
0,78 $
Beta
1,55
Shares outstanding
262,61 մլն
No. of employees
10 հզր
News stories
From web sources and news partners
Simply Wall Street
·
2 րոպե առաջ
Will Higher Royalty Revenue Change Vicor (VICR) Stock Narrative
Simply Wall Street
·
1 ժամ առաջ
Why Peloton Interactive Fell Even As Profit Rose
Nasdaq
·
14 ժամ առաջ
WISeSat.Space Holdings Corp. Rings the Opening Bell
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 հզր
Founded1923
HeadquartersՋերսի Սիթի, Նյու Ջերսի, Միացյալ Նահանգներ
Sector-
Websiteorganon.com